Clinical Trial: ECOG-ACRIN EA6134

ECOG-ACRIN EA6134

Status: Closed

DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial

EA6134 is closed to accrual, effective September 30, 2021.